Greiner Bio-One Showcases VACUETTE Virus Stabilization Tube for Transport and Storage of COVID-19 Swab Samples
|
By LabMedica International staff writers Posted on 17 Dec 2020 |
|
Image: VACUETTE Virus Stabilization Tube (Photo courtesy of Greiner Bio-One)
Greiner Bio-One (Monroe, NC, USA) showcased its new VACUETTE Virus Stabilization Tube that supports the safe transport and storage of specimens, including COVID-19 swab samples, at the 2020 AACC Annual Scientific Meeting.
At the AACC Virtual 2020 Annual Scientific Meeting & Clinical Lab Expo, Greiner demonstrated how its VACUETTE Virus Stabilization Tube can help alleviate some of the barriers to testing for SARS-CoV-2 that laboratories are experiencing. There has been a continued lack of available testing supplies, making it difficult to test the general population for determining the actual disease prevalence. Supplies include swabs for specimen collection and sterile tubes filled with some form of viral or universal transport media (VTM or UTM), which are in short supply around the world.
The FDA has recommended the use of phosphate buffered saline (PBS), in instances where typical transport media is not available, as an acceptable alternative to stabilize specimens within the transport tubes being sent to the lab for subsequent testing during this emergency situation. These transport tubes also allow for storage for up to 72h at 4°C. This means of transport will vastly improve the access to testing because PBS is more readily available than media. Greiner Bio-One has been able to transition production from blood collection tubes to PBS-filled, sterile tubes on a large scale to help reduce the shortage of specimen collection supplies for molecular testing, which remains the recommended method for diagnosis of COVID-19.
VACUETTE Virus Stabilization Tubes are intended for the transport and storage of nasopharyngeal and oropharyngeal swab specimens. Meant for use by healthcare professionals for SARS-CoV-2 testing only, VACUETTE Virus Stabilization Tubes are made of PET with a pre-defined volume of a phosphate buffer saline solution at a pH of 7.4±0.2 to allow for the storage of the SARS-CoV-2 swab specimens for up to 72h at 4°C. The tubes are fitted with VACUETTE Safety Caps and the tube interior is sterile. The product is single use only and can be used on a single patient only. The CE-marked VACUETTE Virus Stabilization Tubes are manufactured according to Greiner Bio-One hygienic standards.
At the AACC Virtual 2020 Annual Scientific Meeting & Clinical Lab Expo, Greiner demonstrated how its VACUETTE Virus Stabilization Tube can help alleviate some of the barriers to testing for SARS-CoV-2 that laboratories are experiencing. There has been a continued lack of available testing supplies, making it difficult to test the general population for determining the actual disease prevalence. Supplies include swabs for specimen collection and sterile tubes filled with some form of viral or universal transport media (VTM or UTM), which are in short supply around the world.
The FDA has recommended the use of phosphate buffered saline (PBS), in instances where typical transport media is not available, as an acceptable alternative to stabilize specimens within the transport tubes being sent to the lab for subsequent testing during this emergency situation. These transport tubes also allow for storage for up to 72h at 4°C. This means of transport will vastly improve the access to testing because PBS is more readily available than media. Greiner Bio-One has been able to transition production from blood collection tubes to PBS-filled, sterile tubes on a large scale to help reduce the shortage of specimen collection supplies for molecular testing, which remains the recommended method for diagnosis of COVID-19.
VACUETTE Virus Stabilization Tubes are intended for the transport and storage of nasopharyngeal and oropharyngeal swab specimens. Meant for use by healthcare professionals for SARS-CoV-2 testing only, VACUETTE Virus Stabilization Tubes are made of PET with a pre-defined volume of a phosphate buffer saline solution at a pH of 7.4±0.2 to allow for the storage of the SARS-CoV-2 swab specimens for up to 72h at 4°C. The tubes are fitted with VACUETTE Safety Caps and the tube interior is sterile. The product is single use only and can be used on a single patient only. The CE-marked VACUETTE Virus Stabilization Tubes are manufactured according to Greiner Bio-One hygienic standards.
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Thrombin Test
i-STAT ACTc Cartridge
New
Immunofluorescence Analyzer
MPQuanti
Latest AACC 2020 News
- All Virtual 2020 AACC Uses Artificial Intelligence to Connect Exhibitors and Attendees
- Stago Diagnostics Transforms Hemostasis with Innovations at AACC 2020 Virtual Event
- Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event
- Seegene Highlights High-Throughput, Single Tube 8-Plex RT-PCR Test for Flu A, Flu B, RSV and COVID-19 with Dual Internal Controls
- Mindray Showcases Total Automated, Scalable Laboratory Solutions for Improving Workflow, Efficiency and Standardization of High Volume Labs
- Beckman Coulter Displays Multidisciplinary Instruments Organized by Size and Workflow Needs in State-of-the-Art 3D Showrooms
- GenScript Demonstrates High-Throughput Measurement of Neutralization Antibody Titers in Serum Samples from SARS-CoV-2 Infected Patients
- Abbott Showcases Next-Generation Alinity Family of Systems at AACC 2020 Virtual Event
- Siemens Demonstrates Groundbreaking, New Innovations in Imaging, Diagnostics and Therapy at AACC 2020 Virtual Event
- Tell Me About It
- Management Skills for Early Career Professionals
- Regulatory Readiness: Tips for Surviving Surveys and Staying in Compliance
- The New and the Next in Brain Health Biomarkers
- The COVID-19 Pandemic: Primed and Prepared
- Content Across the Gamut
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
Neutrophils, once believed to be uniform in nature, have been discovered to exhibit significant diversity. These immune cells, which play a crucial role in fighting infections, are also implicated in autoimmune... Read more
First-of-its-Kind Blood Test Detects Trauma-Related Diseases
In today’s fast-paced world, stress and trauma have unfortunately become common experiences for many individuals. Continuous exposure to stress hormones can confuse the immune system, causing it to misinterpret... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
